Literature DB >> 16866777

Cellular basis of sex disparities in human cardiac electrophysiology.

A O Verkerk1, R Wilders, W de Geringel, H L Tan.   

Abstract

AIM: Sex disparities in electrocardiogram variables and dysrhythmia susceptibility exist, notably in long QT syndrome (LQTS) and Brugada syndrome, but the underlying mechanisms in man are unknown. We studied the cellular basis of sex distinctions in human cardiac electrophysiology and dysrhythmia susceptibility using mathematical models of human ventricular myocytes.
METHODS: We implemented sex differences in the Priebe-Beuckelmann and ten Tusscher-Noble-Noble-Panfilov human ventricular cell models by modifying densities of the L-type Ca(2+) current (I(Ca,L)), transient outward K(+) current (I(to)), and rapid delayed rectifier K(+) current (I(Kr)), according to experimental data from male and female hearts of various species. Sex disparities in transmural repolarization were studied in transmural strands of cells with ion current densities based on canine experimental data.
RESULTS: Female cells have longer action potential duration (APD), steeper APD-heart rate relationship, larger transmural APD heterogeneity, and a greater susceptibility to pro-dysrhythmogenic early afterdepolarizations (EADs) than male cells. Conversely, male cells have more prominent phase-1 repolarization and are more susceptible to all-or-none repolarization.
CONCLUSION: Sex differences in I(Ca,L), I(to) and I(Kr) densities may explain sex disparities in human cardiac electrophysiology. Female cells exhibit a limited 'repolarization reserve' as demonstrated by their larger susceptibility to EADs, which, combined with their larger transmural electrical heterogeneity, renders them more vulnerable to tachydysrhythmias in LQTS. Conversely, male cells have a limited 'depolarization reserve', as shown by their larger susceptibility to all-or-none repolarization, which facilitates tachydysrhythmias in Brugada syndrome. These general principles may also apply to dysrhythmia susceptibility in common disease.

Entities:  

Mesh:

Year:  2006        PMID: 16866777     DOI: 10.1111/j.1748-1716.2006.01586.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  7 in total

1.  Re-evaluating the efficacy of beta-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling.

Authors:  Rebecca C Ahrens-Nicklas; Colleen E Clancy; David J Christini
Journal:  Cardiovasc Res       Date:  2009-03-05       Impact factor: 10.787

2.  Age of natural menopause and atrial fibrillation: the Framingham Heart Study.

Authors:  Jared W Magnani; Carlee B Moser; Joanne M Murabito; Kerrie P Nelson; Joao D Fontes; Steven A Lubitz; Lisa M Sullivan; Patrick T Ellinor; Emelia J Benjamin
Journal:  Am Heart J       Date:  2012-03-29       Impact factor: 4.749

Review 3.  The regulation of the small-conductance calcium-activated potassium current and the mechanisms of sex dimorphism in J wave syndrome.

Authors:  Mu Chen; Yudong Fei; Tai-Zhong Chen; Yi-Gang Li; Peng-Sheng Chen
Journal:  Pflugers Arch       Date:  2021-01-07       Impact factor: 3.657

4.  Evaluating the Impact of Sex and Gender in Brugada Syndrome.

Authors: 
Journal:  J Innov Card Rhythm Manag       Date:  2019-02-15

Review 5.  Disease Modifiers of Inherited SCN5A Channelopathy.

Authors:  Arie O Verkerk; Ahmad S Amin; Carol Ann Remme
Journal:  Front Cardiovasc Med       Date:  2018-10-01

6.  Estrogen regulation of cardiac cAMP-L-type Ca2+ channel pathway modulates sex differences in basal contraction and responses to β2AR-mediated stress in left ventricular apical myocytes.

Authors:  Jeremiah Ong'achwa Machuki; Hong-Yuan Zhang; Juan Geng; Lu Fu; Gabriel Komla Adzika; Lijuan Wu; Wenkang Shang; Jinxia Wu; Li Kexue; Zhiwei Zhao; Hong Sun
Journal:  Cell Commun Signal       Date:  2019-04-15       Impact factor: 5.712

Review 7.  Sex-Related Differences in Genetic Cardiomyopathies.

Authors:  Alessia Argirò; Carolyn Ho; Sharlene M Day; Jolanda van der Velden; Elisabetta Cerbai; Sara Saberi; Jil C Tardiff; Neal K Lakdawala; Iacopo Olivotto
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.